EP3886820
SAMSETNINGAR BURÐAREFNIS
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
27.11.2019EP published:
12.4.2023EP application number:
19889873.6
EP translation filed:
8.5.2023Grant published:
15.7.2023EPO information:
European Patent Register
Max expiry date:
26.11.2039Expiry date:
26.11.2026Next due date:
30.11.2026
Title in English:
CAPSULE FORMULATIONSLanguage of the patent:
English
Timeline
Today
27.11.2019EP application
12.4.2023EP Publication
8.5.2023Translation submitted
15.7.2023Registration published
26.11.2026Expires
Owner
Name:
ChemoCentryx, Inc.Address:
One Amgen Drive , Thousand Oaks, CA 91320, US
Inventor
Name:
LELETI, Manmohan ReddyAddress:
Dublin, California 94568, US
Name:
POWERS, Jay P.Address:
Pacifica, California 94044, US
Agent
Name:
Tego IP ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
201862773848 PDate:
30.11.2018Country:
US
Classification
Categories:
A61K 9/48, A61K 31/451, A61K 47/10, A61K 47/14, A61K 47/40, A61K 47/44
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 6.11.2023
Expires: 26.11.2024
Payer: Árnason Faktor ehf.
Number: 6
Paid: 25.10.2024
Expires: 26.11.2025
Payer: Árnason Faktor ehf.
Number: 7
Paid: 17.11.2025
Expires: 26.11.2026
Payer: Árnason Faktor ehf.